Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulsed hydrocortisone replacement therapy in adrenal insufficiency
2012-001104-37Phase 2Unknown
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of hydrocortisone in Addison's disease, congenital adrenal hyperplasia (CAH) and hypoadrenocorticism (2 arms), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Physiological cortisol rhythmicity and hormonal suppression. Status: unknown.
02
Drugs
hydrocortisone
03
Conditions
Addison's diseasecongenital adrenal hyperplasia (CAH)hypoadrenocorticism
Beyond the preview
Go deeper on 2012-001104-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001104-37.